| |
|
|
 |
|
print
|
|
|
|
|
How it All Started |
| Lonza started a new technology initiative in 2003 with the stated goal to bring pharmaceutical production technologies in line with modern, sustainable chemical and engineering practices such as those already in place within the petrochemical industry, where lower profit margins have accelerated the pace of change.
For several years, the MicroReactor team at Lonza designed and tested microstructured devices in continuous-flow plants, performed lab studies of pharmaceutical reactions and successfully transferred them to commercial production. These reactions are usually hazardous with unstable intermediates, which can be safely operated under intensified process conditions. Thus, this research work has enabled the development of new industrial pharmaceutical processes with low energy and material consumption, which can also be used in fine and specialty chemical industries. |
Growing Experience
|
|
(click to follow link) |
With growing experience, the MicroReactor team developed an in-house modular microreactor system, which has received high praise from the market and is now directly promoted with the support of an experienced market partner, Ehrfeld Mikrotechnik BTS.
Most of the conventional parts of the Lonza system can be manufactured in Lonza’s own workshops and delivered to our customers. The unique microstructured devices have been manufactured by external partners, who are specialized in exact milling and bonding of chemical resistive alloys; but more recently, Lonza’s mechanical workshop is also able to fabricate tiny structures in stainless steel and other alloys.
|
|
|
|
|
|
|
|
|
 |
